General Mills appoints Joan Bottarini to board of directors; declares $0.61 quarterly dividend

This filing

On January 26, 2026, the Board of Directors amended and restated the Company’s By-Laws to, among other things: i. revise procedures and disclosure requirements for the nomination of directors and the submission of proposals for consideration at annual meetings of the stockholders of the Company; ii. revise the majority voting provision to clarify when an election will be deemed contested; and iii. make certain administrative, modernizing, clarifying and conforming changes.

Comparable filing

the Board of Directors of the Company amended Section 3.3 of Article III of the Company’s Amended and Restated By-Laws (the “ By-Laws Amendment ”) to permit the removal of a director with or without cause by the affirmative vote of two-thirds of the outstanding shares of capital stock of the Company entitled to vote at a meeting of shareholders duly called for such purpose. The effective date of the By-Laws Amendment is May 8, 2026.

This filing

On January 26, 2026, the Board of Directors amended and restated the Company’s By-Laws to, among other things: i. revise procedures and disclosure requirements for the nomination of directors and the submission of proposals for consideration at annual meetings of the stockholders of the Company; ii. revise the majority voting provision to clarify when an election will be deemed contested; and iii. make certain administrative, modernizing, clarifying and conforming changes.

Comparable filing

Article III, Section 2 of the Company’s By-Laws was amended to decrease the number of directors to thirteen, effective April 28, 2026.

This filing

On January 26, 2026, the Board of Directors amended and restated the Company’s By-Laws to, among other things: i. revise procedures and disclosure requirements for the nomination of directors and the submission of proposals for consideration at annual meetings of the stockholders of the Company; ii. revise the majority voting provision to clarify when an election will be deemed contested; and iii. make certain administrative, modernizing, clarifying and conforming changes.

Comparable filing

On April 30, 2026, the Board of the Company approved Amended and Restated Bylaws of the Company to provide that the lead independent director (if any) may call special meetings of the Board and will act as chair of meetings of the Company’s stockholders and of the Board in the absence, inability, or refusal to act of the Chair of the Board. In addition, in the event of a vacancy in the office of Chair because of death, resignation, removal, disqualification, or otherwise in which the Board does not appoint a successor Chair, the lead independent director (if a lead independent director has been duly elected) or Chief Executive Officer (if no lead independent director has been duly elected) shall be the Chair and assume the duties, responsibilities, and authority of the office of Chair until a successor is appointed by the Board.

This filing

On January 26, 2026, the Board of Directors amended and restated the Company’s By-Laws to, among other things: i. revise procedures and disclosure requirements for the nomination of directors and the submission of proposals for consideration at annual meetings of the stockholders of the Company; ii. revise the majority voting provision to clarify when an election will be deemed contested; and iii. make certain administrative, modernizing, clarifying and conforming changes.

Comparable filing

stockholders approved certain amendments (the “ Charter Amendments ”) to the Company’s Restated Certificate of Incorporation (the “ Certificate of Incorporation ”).

This filing

On January 26, 2026, the Board of Directors amended and restated the Company’s By-Laws to, among other things: i. revise procedures and disclosure requirements for the nomination of directors and the submission of proposals for consideration at annual meetings of the stockholders of the Company; ii. revise the majority voting provision to clarify when an election will be deemed contested; and iii. make certain administrative, modernizing, clarifying and conforming changes.

Comparable filing

the reincorporation of the Company from the State of Delaware to the State of Nevada (the “Reincorporation”) became effective on June 1, 2026, at 12:02 a.m. Pacific Time

This filing

On January 26, 2026, the Board of Directors amended and restated the Company’s By-Laws to, among other things: i. revise procedures and disclosure requirements for the nomination of directors and the submission of proposals for consideration at annual meetings of the stockholders of the Company; ii. revise the majority voting provision to clarify when an election will be deemed contested; and iii. make certain administrative, modernizing, clarifying and conforming changes.

Comparable filing

On March 26, 2026 the Company amended ARTICLE FIRST of its Certificate of Incorporation and changed its name to Gemaxel Inc. from Worlds Inc.

This filing

On January 26, 2026, the Board of Directors amended and restated the Company’s By-Laws to, among other things: i. revise procedures and disclosure requirements for the nomination of directors and the submission of proposals for consideration at annual meetings of the stockholders of the Company; ii. revise the majority voting provision to clarify when an election will be deemed contested; and iii. make certain administrative, modernizing, clarifying and conforming changes.

Comparable filing

On May 29, 2026, the board of directors of BTCS Inc. (the “Company”) approved an amendment to the Company’s Amended and Restated Bylaws (the “Bylaws”) and adopted an amendment to the quorum requirement contained in Article II, Section 2.9 of the Bylaws (the “Amendment”) to provide that the holders of thirty-three and one third percent (33.3%) of the voting power of the Company entitled to vote at a meeting of stockholders, present in person or represented by proxy, shall constitute a quorum for the transaction of business.

This filing

On January 26, 2026, the Board of Directors amended and restated the Company’s By-Laws to, among other things: i. revise procedures and disclosure requirements for the nomination of directors and the submission of proposals for consideration at annual meetings of the stockholders of the Company; ii. revise the majority voting provision to clarify when an election will be deemed contested; and iii. make certain administrative, modernizing, clarifying and conforming changes.

Comparable filing

On May 6, 2026 , the Board of Directors (the “Board”) of Moderna, Inc. (the “Company”) approved an amendment to the Company’s Second Amended and Restated By-Laws (the “By-Law Amendment”), effective immediately, to designate the federal district courts of the United States as the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, unless the Company consents in writing to the selection of an alternative forum.